A new case confirming and expanding the phenotype spectrum of ADAT3-related intellectual disability syndrome.
ADAT3 gene mutation
Arabs in Israel
Clinical manifestations
Intellectual disability syndrome
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
26
07
2018
revised:
30
09
2018
accepted:
04
10
2018
pubmed:
9
10
2018
medline:
7
2
2020
entrez:
9
10
2018
Statut:
ppublish
Résumé
The present study describes two patients with clinical diagnosis of ID, from a consanguineous family in Israel. Whole exome sequencing identified a homozygous missense mutation in the ADAT3 gene. The clinical features of our patients were compared with several cases described in two recently published studies that documented clinical manifestation of this same mutation. Both affected siblings in our study expressed the previously described clinical features such as intellectual disability, strabismus, FTT/underweight, microcephaly and hypotonia. Interestingly, our patients suffered from additional clinical manifestations that were not detailed in the previous two studies, such as: gait difficulties, instability, teeth abnormalities, neuropathy and contractures of the hand wrist and fingers. We conclude that the ADAT3 gene mutation is responsible for ADAT3-related ID syndrome, which induces the variety clinical manifestations exhibited by our patients. Further studies aimed at identifying and characterizing additional afflicted families worldwide will be required to obtain a more comprehensive understanding of this syndrome.
Identifiants
pubmed: 30296593
pii: S1769-7212(18)30574-3
doi: 10.1016/j.ejmg.2018.10.001
pii:
doi:
Substances chimiques
RNA-Binding Proteins
0
ADAT3 protein, human
EC 3.5.4.4
Adenosine Deaminase
EC 3.5.4.4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103549Informations de copyright
Copyright © 2018 Elsevier Masson SAS. All rights reserved.